- NEGATIVE
Quarterly Revenue Gian Life Care Dec-2025 Quarterly Revenue is Rs 1 Cr which is growth of -30.7% YoY.
- NEGATIVE
Quarterly Net Profit Gian Life Care Dec-2025 Quarterly Net Profit is Rs 0 Cr which is growth of -68.2% YoY.
aboutGian Life Care Ltd. is an Indian healthcare company primarily engaged in the diagnostic and pathology services sector. The company operates through a network of diagnostic centers and collection points, providing a range of clinical laboratory tests ... Read More
4.17-0.07(-1.65%)
3,158
BSE Volume
BSE 30 Oct, 2026 3:31 PM (IST)
Please subscribe to view forecaster data
Check Before You Buy
VIEW FULL CHECKLISTLow rank
5Positive15Negative
25.0%Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
Gian Life Care Stock Price Analysis
Day Price Range-1.6% 1 Day return | 4.2 (LTP) 4.24.3 LowHigh |
|---|---|
Week Price Range-0.7% 1 Week return | 4.2 (LTP) 3.94.3 LowHigh |
Month Price Range-11.1% 1 Month return | 4.2 (LTP) 3.94.8 LowHigh |
52 Week Price Range-66.6% 1 Year return | 4.2 (LTP) 3.913.2 LowHigh |
Competitors/Peers
Quarterly
Annual
Balance Sheet
Ratios
Cash Flow
Documents
Gian Life Care quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2 | 0.8 | 1 | 0.9 | 1.8 | 2.1 | 2.2 | 4.8 | 4 | 2.5 | 2.6 | 1.7 | 5.3 | ||
Operating Exp. | 0.9 | 1.1 | 0.7 | 1.1 | 1.1 | 1.7 | 1.8 | 1.5 | 1.6 | 2 | 1.9 | 2.3 | 2.8 | |
Operating Profit | 0.3 | -0.4 | 0.1 | 0.5 | 0.2 | 0.2 | 3.1 | 2.2 | 0.3 | 0.5 | -0.7 | 2.3 | ||
Operating Profit Margin % | 22.44% | -58.61% | 15.55% | 0.31% | 30.26% | 11.46% | 11.26% | 67.41% | 59.09% | 14.24% | 21.11% | -46.43% | 45.00% | |
Depr. | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
Profit Before Tax | 0.1 | -0.5 | 0.1 | -0.5 | 0.4 | 0.2 | 0.2 | 3.1 | 2.2 | 0.2 | 0.4 | -0.8 | 2.2 | |
Tax | -0 | -0 | 0 | 0 | 0 | 0 | 0.1 | 0.9 | 0.5 | 0 | 0.1 | 0.1 | 0.3 | |
Net Profit | 0.1 | -0.5 | 0.1 | -0.5 | 0.4 | 0.1 | 0.1 | 2.2 | 1.6 | 0.2 | 0.3 | -0.9 | 1.9 | |
EPS Adj. latest | 0.1 | -0.5 | 0.1 | -0.5 | 0.4 | 0.1 | 0.1 | 2.1 | 1.6 | 0.2 | 0.3 | -0.9 | 1.8 | |
Net profit TTM | -0.8 | -0.5 | 0.1 | 0.2 | 2.8 | 4.1 | 4.1 | 4.3 | 1.2 | 1.5 | 1.8 | 1.5 | 1.2 | |
Basic EPS TTM | -0.7 | -0.5 | 0.1 | 0.2 | 2.7 | 3.9 | 4 | 4.2 | 1.2 | 1.4 | 1.7 | 1.4 | 1.2 | |
Results PDF | ||||||||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Gian Life Care Technical Analysis
Gian Life Care EMA & SMA
Bearish-8
0 bullish, 8 bearish
Bullish0
Bearish8
| 5 Day | 4.2 |
|---|---|
| 10 Day | 4.3 |
| 12 Day | 4.3 |
| 20 Day | 4.4 |
| 26 Day | 4.4 |
|---|---|
| 50 Day | 4.6 |
| 100 Day | 5.0 |
| 200 Day | 6.5 |
Gian Life Care Delivery And Volume
Daily Avg. Delivery Volume %
30 Oct, 2026100.0%
Week100.0%
Month100.0%
Legend
Positive IndicatorNeutral IndicatorNegative Indicator
Gian Life Care Resistance and Support
4.23
Pivot
| First Resistance | 4.3 |
|---|---|
| Second Resistance | 4.4 |
| Third Resistance | 4.5 |
| First Support | 4.1 |
|---|---|
| Second Support | 4.1 |
| Third Support | 3.9 |
| Day RSI | 38.9 |
|---|---|
| Day MACD | -0.1 |
| Day MFI | 44.9 |
| Day MACD Signal Line | -0.1 |
Gian Life Care Beta
| 1 Month | 0.8 |
|---|---|
| 1 Year | 0.4 |
| 3 Month | 0.4 |
|---|---|
| 3 Year | 0.4 |
Gian Life Care Price Change Analysis
↓-11.1%
Over 1 Month
LowHigh
3.94.8
↓-14.9%
Over 3 Months
LowHigh
3.95.1
↓-35.6%
Over 6 Months
LowHigh
3.96.8
↓-66.6%
Over 1 Year
LowHigh
3.913.2
Gian Life Care Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| BRAHMA HOSPITAL HUF | Bulk | Purchase | 13 Mar 2026 | 7.61 | 67,690 | BSE |
| HARISH KUMAR | Bulk | Sell | 13 Mar 2026 | 7.61 | 67,690 | BSE |
| TEJESH HASMUKH SHAH | Bulk | Purchase | 17 Mar 2025 | 17.92 | 58,155 | BSE |
| HARISH KUMAR | Bulk | Purchase | 07 Feb 2025 | 16.76 | 80,000 | BSE |
| ARUN KUMAR GUPTA | Bulk | Purchase | 29 Nov 2024 | 19.66 | 65,217 | BSE |
| ARUN KUMAR GUPTA | Bulk | Sell | 28 Nov 2024 | 18.36 | 62,000 | BSE |
| ARUN KUMAR GUPTA | Bulk | Purchase | 04 Nov 2024 | 22.20 | 70,000 | BSE |
| ARUN KUMAR GUPTA | Bulk | Sell | 31 Oct 2024 | 18.16 | 70,000 | BSE |
| SUNDIIP DEVAADIGAA | Bulk | Sell | 13 Sep 2024 | 23.11 | 297,805 | BSE |
| GAURAV MANOCHA | Bulk | Purchase | 13 Sep 2024 | 23.16 | 84,000 | BSE |
Gian Life Care Corporate Actions
Gian Life Care Bonus shares
Gian Life Care bonus history along with announcement, record, ex-bonus dates, and bonus ratios.
#Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
129 Mar 2022 | 6:5 | 30 Mar 2022 |
Gian Life Care Board Meetings
Gian Life Care past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
114 Feb 2026 | Quarterly Results | - |
228 Jan 2026 | Quarterly Results | (Revised) |
314 Aug 2025 | Quarterly Results | - |
414 Feb 2025 | Quarterly Results | - |
514 Nov 2024 | Quarterly Results | - |
Gian Life Care Corporate Filings
Gian Life Care BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 21 Apr 2026 | Gian Life Care Ltd - 542918 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Please find attached herewith Certificate under regulation 74(5) for the Quarter ended March 31, 2026. For Gian Life Care Limited | |
| 04 Mar 2026 | Gian Life Care Ltd - 542918 - Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Approval To Enter Into Hospital Lab Management Services With M/S. Brahma Hospital (HUF) | Dear Sir/Maam, The Company has entered into Hospital lab Management Services Agreement with M/s. Brahma Hospital (HUF). Detailed intimation is attached. Regards Gian Life Care Limited | |
| 14 Feb 2026 | Gian Life Care Ltd - 542918 - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, February 14, 2026 | Pursuant to the provisions of Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today i.e. February 14, 2026, has inter-alia considered and approved the following: - 1. Unaudited Standalone and Consolidated Financial results of the Company for the Quarter/ Period ended December 31, 2025. (Copy enclosed along with Limited Review Report). The Board Meeting commenced at 04:30 P.M and concluded at 05.30 P.M. | |
| 09 Feb 2026 | Gian Life Care Ltd - 542918 - Board Meeting Intimation for Intimation Of Board Meeting To Consider And Approve Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Period Ended On 31St December, 2025 | Gian Life Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve As per the captioned subject, it is hereby informed that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday, the 14th day of February, 2026 at Kanpur: 1. To interallia consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter/ Period ended 31st December, 2025. 2. Any other business which forms part of the Agenda Paper. Further, we hereby inform that the trading window for dealing in shares of the Company has already been closed from 01st January, 2026 and shall remain closed till completion of 48 hours after such information is made public for all Directors, KMP's, Designated Employees and Connected Persons of the Company as defined in the Code. | |
| 28 Jan 2026 | Gian Life Care Ltd - 542918 - Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter/ Half Year Ended 30Th September, 2025 | Dear Sir/ Maam, Please find attached herewith Unaudited Standalone and Consolidated Financial Results for the quarter/ half year ended September 30, 2025. Kindly take the same on record. For Gian Life Care Limited |
Gian Life Care Documents
Gian Life Care Annual Reports
Gian Life Care financials, including annual results, balance sheets, and cash flow statements.
Gian Life Care Investor Presentations
Gian Life Care investor presentations, including business updates, financial insights, and strategic initiatives.
| Date | Report Title | Links |
|---|---|---|
| 16 Nov 2021 | Gian Life Care Ltd - 542918 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
Gian Life Care - Company Profile
Gian Life Care Management Structure
Gian Life Care management structure with salaries, total experience, and qualifications.
Gian Life Care Board of Directors
Gian Life Care Board of directors with salaries, total experience, and qualifications.
Website: www.gianpathlabs.com
About the company - Business Profile
Gian Life Care Ltd. is an Indian healthcare company primarily engaged in the diagnostic and pathology services sector. The company operates through a network of diagnostic centers and collection points, providing a range of clinical laboratory tests and healthcare services. Headquartered in Kanpur, Uttar Pradesh, the company plays a role in the regional healthcare ecosystem by offering diagnostic solutions to individual patients, hospitals, and other healthcare providers.
Key Points
- Key Facts: Gian Life Care Ltd. was incorporated on November 5, 2018. It is headquartered in Kanpur, Uttar Pradesh. The company is listed on the BSE (Stock Code: 16550455).
- Operations and Assets: The company operates diagnostic laboratories under the brand Gian Path Labs and Wellness Diagnostics. As of March 31, 2025, its non-current assets included property, plant, and equipment valued at ₹378.02 lacs, which includes specialized plant and equipment (₹312.23 lacs) and medical vehicles. It also holds investments in subsidiaries and LLPs such as Gian Path To Health Pvt Ltd and Gian Satguru Pathology LLP.
- Revenue Breakdown: For the fiscal year ended March 31, 2025, the company reported:
- Revenue from Operations: ₹683.10 lacs (a decrease from ₹1,311.98 lacs in FY2024).
- Other Income: ₹24.53 lacs, primarily from interest income.
- The business is concentrated in the healthcare diagnostic services segment within India.
- Business Model: Gian Life Care operates on a service-based model, generating revenue through pathology tests and diagnostic screenings. It focuses on accessibility through its collection centers and utilizes medical equipment for high-volume testing.
- Employee and Management: The company is led by Director Arun Kumar Gupta and CFO Avani Gupta. As of early 2026, the promoter holding stood at approximately 33.12%, with Arun Kumar Gupta holding 29% of the shares.
- Financial Performance (FY2025 vs FY2024):
- Net Profit: ₹15.53 lacs in FY2025 compared to ₹429.55 lacs in FY2024.
- Total Expenses: ₹658.03 lacs in FY2025, with major components being other expenses (₹390.48 lacs) and cost of materials consumed (₹120.28 lacs).
- Earnings Per Share (EPS): ₹0.14 for FY2025, down from ₹4.16 in the previous year.
- Recent Strategic Initiatives: The company continues to maintain its infrastructure, with capital work-in-progress of ₹13.75 lacs as of March 2025. Recent quarterly results (ending September 30, 2025) showed a consolidated revenue of ₹66.01 lacs for the quarter, reflecting a challenging operational period with a net loss of ₹51.21 lacs for that specific three-month interval.
References